GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes

Marx, Nikolaus; Husain, Mansoor; Lehrke, Michael; Verma, Subodh; Sattar, Naveed

doi:10.1161/circulationaha.122.059595

Public

GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes

Published in Circulation • Dec 12, 2022

Authors:

Nikolaus Marx

Mansoor Husain

Michael Lehrke

Abstract

Patients with type 2 diabetes are at high risk for development of cardiovascular disease, including myocardial infarction, stroke, heart failure, and cardiovascular death. Multiple large cardiovascular outcome trials with novel glucose-lowering agents, namely SGLT2i (SGLT2 inhibitors) and GLP-1 RA (...

Subject

Medicine

Diabetes mellitus

Type 2 diabetes

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!